InvestorsHub Logo
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Re: MWM post# 11123

Monday, 07/27/2020 5:47:57 PM

Monday, July 27, 2020 5:47:57 PM

Post# of 42716
“We are thrilled that NIH selected lenzilumab to be part of its Big Effect Trial,” said Cameron Durrant, MD, MBA, chief executive officer of Humanigen. “With data from the BET and our ongoing Phase III study, we will have data from approximately 500 hospitalized COVID-19 patients.” Locked and loaded.